PlateletBio
Bruce Zetter, Ph.D., is professor of cancer biology and surgery at Harvard Medical School, researcher at Boston Children’s Hospital and discoverer of the world’s first angiogenesis inhibitor.
This person is not in the org chart
This person is not in any offices
PlateletBio
PlateletBio is the only allogeneic cell therapy company focused on platelet biology. The company's approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, they're developing a superior cell therapy empowered to tackle previously unmet medical challenges.